Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer
NCT01627197 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 186
Last updated 2024-11-05
Summary
Effect of adjuvant intra-arterial chemotherapy to control tumor progression in patients cystectomized for locally advanced bladder cancer.
Conditions
Interventions
- PROCEDURE
-
Surgery of percutaneous catheter system
Intraarterial (IA) catheterization was done in the Department of Invasive Technology. All medications were administered using percutaneous catheter system via a modified Seldinger technique. An angiographic catheter was inserted through the femoral artery into the internal iliac artery. The catheter tips were located superior to the origin of bilateral common artery.
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Fang-Jian Zhou, M.D Ph.D · Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
Countries
- China
Study Locations
More Related Trials
-
Molecular Markers of Chemosensitivity for Bladder Cancer
NCT02074241 ·Status: UNKNOWN
-
Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer
NCT02861196 ·Status: COMPLETED ·Phase: NA
-
Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy
NCT04966975 ·Status: UNKNOWN
-
Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma
NCT05276167 ·Status: RECRUITING ·Phase: NA
-
Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy
NCT07053722 ·Status: NOT_YET_RECRUITING
-
Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer
NCT00867347 ·Status: COMPLETED ·Phase: PHASE3
-
Survival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder Cancer
NCT06727214 ·Status: NOT_YET_RECRUITING
-
Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
NCT04060459 ·Status: UNKNOWN ·Phase: PHASE2
-
Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma
NCT04812145 ·Status: UNKNOWN
-
Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
NCT05397262 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC
NCT02876861 ·Status: COMPLETED ·Phase: PHASE2
-
HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer
NCT06327932 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer
NCT05445648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma
NCT04570410 ·Status: COMPLETED ·Phase: PHASE2
-
Medical Imaging in Bladder Tumors by MRI
NCT06033040 ·Status: RECRUITING
-
A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer
NCT06074484 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT
NCT03689478 ·Status: COMPLETED ·Phase: NA
-
A Study of RC48-ADC Combined With Cadonilimab(AK104)in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma
NCT06178601 ·Status: RECRUITING ·Phase: PHASE2
-
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
NCT02944357 ·Status: WITHDRAWN ·Phase: NA
-
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
NCT00003725 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
NCT05917158 ·Status: RECRUITING ·Phase: PHASE2
-
Adaptive Radiotherapy for Genitourinary Cancers
NCT07324798 ·Status: RECRUITING ·Phase: NA
-
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
NCT07261592 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
NCT07043790 ·Status: COMPLETED ·Phase: NA